Home » Topics » BioWorld Science

BioWorld Science
RSS

Pfizer enters phase I trials with CP-358774

Aug. 20, 1997

Endorex licenses anticancer drug perillyl alcohol

Aug. 20, 1997

Bristol-Myers Squibb describes new taxanes

Aug. 19, 1997

Efficacy of long-term treatment with dronabinol for AIDS-related anorexia

Aug. 19, 1997

Antidepressant activity described for 5-HT reuptake inhibitor/5-HT antagonist

Aug. 19, 1997

Tachykinin antagonist with potential as antiasthmatic

Aug. 19, 1997

Novel immunotoxins for the treatment of AIDS

Aug. 19, 1997

Clobenpropit shows memory-enhancing activity in preclinical models

Aug. 19, 1997

Analgesic mGluR antagonists reported in patent literature

Aug. 19, 1997

Optison evaluated in phase II trials for myocardial perfusion imaging

Aug. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....